AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Palbociclib in Nigeria
3 products registered with NAFDAC — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Ibrance 125 mg Capsules** Capsule | B4-9327 | Pfizer Specialties Ltd | active | 30 Jul 2029 |
| Ibrance 75 mg Capsules** Capsule | B4-9329 | Pfizer Specialties Ltd | active | 30 Jul 2029 |
| Ibrance 100 mg Capsules** Capsule | B4-9328 | Pfizer Specialties Ltd | active | 30 Jul 2029 |
Palbociclib — NAFDAC Registration Details
NAFDAC (Nigeria) has 3 registered products containing Palbociclib, of which 3 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Palbociclib registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.